Self-desciplined framework in Japan to bring advanced therapy projects to bedside in the world

DOI Web Site 10 References
  • Egami Mime
    Institute of Advanced Biomedical Engineering & Science, Tokyo Women's Medical University

Bibliographic Information

Other Title
  • ２０１０年問題の解決策を考える　　日本発を世界に　　先端医療を実現する自主自律開発体制の構築
  • 日本発を世界に--先端医療を実現する自主自律開発体制の構築
  • ニホンハツ オ セカイ ニ センタン イリョウ オ ジツゲン スル ジシュ ジリツ カイハツ タイセイ ノ コウチク
  • 先端医療を実現する自主自律開発体制の構築

Search this article

Abstract

Japanese Government announced New Growth Strategy for “Life Innovation” to lead sustainable growth, international contribution and creation of ¥4.5 trillion market and, 2.8million jobs by 2020 in Japan, while net import surplus of pharmaceuticals & medical devices exceeded ¥2.56 trillion in FY2009. This aggressive strategy has to be translated into challenging actions by newly set up Medical Innovation Promotion Office. EU and the United States have already been taking timely actions to establish brand new development framework for advanced therapy such as regenerative medicine which framework vision is still missing in Japan. By observing innovative progress of “Cell Sheet Engineering” regenerative medicine and newly established industry consortium in Japan, FIRM(Forum for Innovative Regenerative Medicine), I would like to discuss essential actions in this country to create self-disciplined development framework for bringing world class advanced therapy to bedside in the World.

Journal

  • Drug Delivery System

    Drug Delivery System 26 (2), 88-98, 2011

    THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM

References(10)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top